Cargando…

Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial

BACKGROUND: Coronary heart disease (CHD) has become a common cardiovascular disease that seriously threatens the health of people. As reperfusion in the early phase and drug therapy, especially percutaneous coronary intervention (PCI), have become widely used in the clinic, the mortality of acute my...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yongxia, Wang, Xinlu, Wang, Jianru, Li, Bin, Yu, Rui, Hu, Yucai, Li, Xingyuan, Peng, Guangcao, Zhang, Mengmeng, Zhu, Mingjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085139/ https://www.ncbi.nlm.nih.gov/pubmed/32197640 http://dx.doi.org/10.1186/s13063-020-4208-4

Ejemplares similares

Integrating Metabolomics and Network Pharmacology to Explore the Mechanism of Tongmai Yangxin Pills in Ameliorating Doxorubicin-Induced Cardiotoxicity
por: Shu, Lexin, et al.
Publicado: (2023)

Tongmai Yangxin pill alleviates myocardial no-reflow by activating GPER to regulate HIF-1α signaling and downstream potassium channels
por: Chen, Ting, et al.
Publicado: (2023)

Mechanism of Yangxin Tongmai Decoction in the Treatment of Coronary Heart Disease with Blood Stasis Syndrome Based on Network Pharmacology and Molecular Docking
por: Zhang, Mengxue, et al.
Publicado: (2022)

Development of a HPLC-MS/MS Method to Determine 11 Bioactive Compounds in Tongmai Yangxin Pill and Application to a Pharmacokinetic Study in Rats
por: Shen, Jiayuan, et al.
Publicado: (2018)

Tongmai Yangxin Pill combined with metoprolol or metoprolol alone for the treatment of symptomatic premature ventricular complex: a multicenter, randomized, parallel-controlled clinical study
por: LIU, Li-Jun, et al.
Publicado: (2022)

Integrated Bioinformatics Analysis and Verification of Gene Targets for Myocardial Ischemia-Reperfusion Injury
por: Wang, Jianru, et al.
Publicado: (2022)

Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials
por: Wei, Jingjing, et al.
Publicado: (2022)

Effects of Tongmai oral liquid in femoral ateriovenous fistula
por: Su, Pei-Ling, et al.
Publicado: (2015)

Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling
por: Yang, Hong-Jie, et al.
Publicado: (2020)

Clinical Effect of Tongmai Fuming Decoction on Neovascular Ophthalmopathy
por: Yang, Lei lei, et al.
Publicado: (2022)

Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis
por: Cheng, Guangqing, et al.
Publicado: (2021)

Predictive value of acoustic cardiography for post-PCI early ventricular remodeling in acute myocardial infarction
por: Wang, Weiwei, et al.
Publicado: (2023)

Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis
por: Zhu, Mingjun, et al.
Publicado: (2022)

Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients
por: Wang, Yu, et al.
Publicado: (2021)

Investigating the cardioprotective effects of Fuzheng Yangxin recipe based on network pharmacology and experimental evaluation
por: Wang, Anzhu, et al.
Publicado: (2022)

Exploring the mechanism of Yizhi Tongmai decoction in the treatment of vascular dementia through network pharmacology and molecular docking
por: Shi, Hongshuo, et al.
Publicado: (2021)

Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy
por: Liu, Bei-Lei, et al.
Publicado: (2018)

Efficacy and safety of TCM Yangxin Anshen Therapy for insomnia: A systematic review and meta-analysis
por: Li, Feizhou, et al.
Publicado: (2020)

Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
por: Liu, Yi, et al.
Publicado: (2023)

Biomarkers of unstable angina pectoris and yangxin decoction intervention: An exploratory metabonomics study of blood plasma
por: Yu, Xiao-hong, et al.
Publicado: (2017)

Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
por: Ma, Jin, et al.
Publicado: (2018)

Efficacy and safety of traditional Chinese medicine yangxin anshen therapy for insomnia: A protocol of systematic review and meta-analysis
por: Li, Feizhou, et al.
Publicado: (2019)

Left ventricular remodeling and function after primary and delayed PCI in patients with recent myocardial infarction
por: Hamila, M, et al.
Publicado: (2005)

Effect of Shensong Yangxin on the Progression of Paroxysmal Atrial Fibrillation is Correlated with Regulation of Autonomic Nerve Activity
por: Zhao, Hong-Yi, et al.
Publicado: (2017)

Study of the Biotransformation of Tongmai Formula by Human Intestinal Flora and Its Intestinal Permeability across the Caco-2 Cell Monolayer
por: Wu, Shuai, et al.
Publicado: (2015)

Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial
por: Wang, Xi, et al.
Publicado: (2017)

Bystander Motivation in Bullying Incidents: To Intervene or Not to Intervene?
por: Thornberg, Robert, et al.
Publicado: (2012)

Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction
por: Zhang, Jiehan, et al.
Publicado: (2023)

Detection of Infectious Agents Causing Neonatal Calf Diarrhea on Two Large Dairy Farms in Yangxin County, Shandong Province, China
por: Wei, Xiaojuan, et al.
Publicado: (2021)

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Wei, Jingjing, et al.
Publicado: (2021)

Yangxin decoction for the treatment of angina pectoris of coronary heart disease: A systematic review of randomized controlled trial
por: Yu, Xiao-hong, et al.
Publicado: (2022)

Huayu Tongmai Granules protects against vascular endothelial dysfunction via up-regulating miR-185 and down-regulating RAGE
por: Liu, Xiaoming, et al.
Publicado: (2018)

Catheter inside the right heart for 22 years: to intervene or not to intervene?
por: Çimen, Tolga, et al.
Publicado: (2015)

To intervene or not to intervene: A case of symptomatic neurocysticercosis complicated by ventriculitis
por: Haq, Syed H., et al.
Publicado: (2023)

Protective Effects of Shenfuyixin Granule on H(2)O(2)-Induced Apoptosis in Neonatal Rat Cardiomyocytes
por: Wang, Xinlu, et al.
Publicado: (2021)

Efficacy of Yangxin Recipe in Combination with Conventional Western Medicine in Treatment of Angina Pectoris of Coronary Heart Disease
por: Liu, Jiali, et al.
Publicado: (2022)

Efficacy and safety of Tongmai Jiangtang capsule combined with conventional therapy in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis
por: Sun, Lin-xi, et al.
Publicado: (2023)

Huatan Dingji Decoction intervening in atrial fibrillation: protocol for a randomized double-blind single-simulated placebo-controlled clinical trial
por: Xiao, Ying, et al.
Publicado: (2021)

Predictors and prognosis of PCI-related myocardial injury in chronic total occlusion
por: Kong, Tianzhong, et al.
Publicado: (2022)

INTERVENING IN THE LONGEVITY NETWORK
por: Mendenhall, Alexander, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_00789rrkpor1900mhf7k5a0dpm